trending Market Intelligence /marketintelligence/en/news-insights/trending/KHGGIWCWqizXtTMKh1Goig2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

SoftBank infuses $1.1B in healthcare startup Roivant

COVID-19 Lockdown Boosted Growth Of Digital Platforms

Q2: U.S. Solar and Wind Power by the Numbers

Mining Exploration Insights – September 2020

Amid Pandemic, Airlines Forge a New Survival Metric: Daily Cash Burn


SoftBank infuses $1.1B in healthcare startup Roivant

SoftBank Group Corp. has led a $1.1 billion equity investment in Switzerland-based healthcare startup Roivant Sciences.

The investment will be made through the Vision Fund, which according to London's Financial Times, is the fund's first backing of a drugmaker and the largest private financing in the healthcare industry.

The investment is the latest in the string of bets recently made by SoftBank.